AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pafre SP 50mg/325mg/10mg Tablet

Prescription Icon
Prescription Required

Marketer

Arlak Biotech Pvt Ltd

Salt Composition

Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)

Overview Pafre SP 50mg/325mg/10mg Tablet

Sovex Relief 50mg/325mg/10mg tablets offer effective pain management. This medication alleviates moderate pain and reduces fever, providing relief from muscle aches, back pain, joint pain, menstrual discomfort, and toothaches. Administer Sovex Relief with food to minimize stomach upset. Dosage and treatment length vary depending on your condition and response. Continue taking the medication as directed, even after symptom improvement, unless your physician advises otherwise. Common side effects include nausea, vomiting, abdominal pain, indigestion, and heartburn. Report any persistent or worsening side effects to your doctor, who can offer strategies for management or symptom reduction. Use the lowest effective dose. Inform your doctor about any pre-existing health conditions or other medications you are using, as interactions are possible. Exercise caution if you have liver or kidney disease, or a history of alcohol abuse. Pregnant or breastfeeding individuals should seek medical advice before using this medication.

Uses of Pafre SP 50mg/325mg/10mg Tablet

Analgesia

Major Benefits of Pafre SP 50mg/325mg/10mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Pafre SP 50mg/325mg/10mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

Common Side effects of Pafre SP 50mg/325mg/10mg Tablet:

  • Nausea
  • Vomiting
  • Stomach pain
  • Indigestion
  • Heartburn
  • Loss of appetite
  • Diarrhea

How to use Pafre SP 50mg/325mg/10mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume Pafre SP 50mg/325mg/10mg tablets with a meal.

How Pafre SP 50mg/325mg/10mg Tablet works:

Each Pafre SP 50mg/325mg/10mg tablet unites diclofenac, paracetamol, and serratiopeptidase to alleviate pain. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic paracetamol reduce pain and fever by inhibiting the production of specific pain and fever-inducing brain chemicals. Serratiopeptidase, an enzyme, aids healing by degrading aberrant proteins at inflamed sites.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Pafre SP 50mg/325mg/10mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Pafre SP 50mg/325mg/10mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Pafre SP 50mg/325mg/10mg Tablet with breastfeeding are lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects of Pafre SP 50mg/325mg/10mg Tablets, such as headaches, blurred vision, dizziness, or drowsiness, which some individuals experience.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Pafre SP 50mg/325mg/10mg tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Pafre SP 50mg/325mg/10mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe or active liver disease.

What if you forget to take Pafre SP 50mg/325mg/10mg Tablet :

Should you forget to take your Pafre SP 50mg/325mg/10mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Pafre SP 50mg/325mg/10mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medications for pain relief

FAQs on Pafre SP 50mg/325mg/10mg Tablet

Store this medication in its original, tightly sealed container, following the storage instructions on the packaging. Discard any remaining medication after use. Prevent access by children, pets, and others.
Diclofenac, Paracetamol, and Serratiopeptidase are combined in Pafre SP 50mg/325mg/10mg tablets to provide pain and inflammation relief. The medication achieves this by reducing the concentration of pain- and inflammation-causing chemicals within the body.
Pafre SP 50mg/325mg/10mg Tablets are generally well-tolerated, but some individuals may experience typical adverse reactions including nausea, vomiting, abdominal discomfort, heartburn, and diarrhea. Promptly report any ongoing issues related to the medication to your physician.
The Pafre SP 50mg/325mg/10mg Tablet is typically prescribed for short-term use and may be stopped once pain subsides. Nevertheless, physician guidance should be followed regarding continued use of the Pafre SP 50mg/325mg/10mg Tablet.
Nausea and vomiting are potential side effects of Pafre SP 50mg/325mg/10mg Tablets. Consuming the tablets with milk, food, or antacids may mitigate nausea. Fatty or fried foods should be avoided while taking this medication. If vomiting occurs, replenish fluids by sipping small amounts of water or other liquids frequently. Persistent vomiting accompanied by dehydration symptoms such as dark, strong-smelling urine and infrequent urination warrants immediate medical consultation. Always consult your physician before taking any additional medications.
Indeed, $ame may induce dizziness in certain individuals, manifesting as faintness, weakness, unsteadiness, or lightheadedness. Should you experience these sensations, rest is advised until symptoms subside. Operating machinery or driving should be avoided.
Patients with hypersensitivity to Pafre SP 50mg/325mg/10mg Tablet components or excipients, or known NSAID allergy, should not take this medication. Its use is contraindicated in individuals with a history of peptic ulcers or active gastrointestinal bleeding. Furthermore, patients with pre-existing heart failure, hypertension, hepatic impairment, or renal disease should avoid this drug.
The analgesic Pafre SP 50mg/325mg/10mg Tablet is compatible with Vitamin B-complex supplements. Pain relief from Pafre SP 50mg/325mg/10mg Tablet may be complemented by addressing potential underlying vitamin deficiencies with Vitamin B-complex.
Taking Pafre SP 50mg/325mg/10mg tablets for stomach pain is not recommended without first seeking medical advice. This medication's potential to heighten stomach acid production could worsen undiagnosed problems.
Exceeding the prescribed dosage of Pafre SP 50mg/325mg/10mg tablets elevates the risk of adverse reactions. For worsening or unrelieved pain despite adhering to the recommended dosage, consult your physician for reassessment.
Pafre SP 50mg/325mg/10mg ...
63
MRP 76
17% off